Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02771236 · ClinicalTrials.gov registry record
Clinical and Molecular Studies in Families With Inherited Eye Disease
A clinical trial of Inherited Eye Disease, sponsored by National Eye Institute (NEI).
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 10
- Study locations
NCT02771236: Recruiting study of Inherited Eye Disease, sponsored by National Eye Institute (NEI).
NCT02771236 is a study of Inherited Eye Disease that is actively recruiting participants, run by National Eye Institute (NEI). The registered enrollment target is 5,000 participants. The trial reports 10 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02771236, a study of Inherited Eye Disease, is actively recruiting participants, sponsored by National Eye Institute (NEI).
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 10
- Study locations
Study Summary
Background: Genes are the basic units of heredity. When genes are changed, certain cells don t work like they should. Researchers want to try to better understand the genetic conditions that are linked with inherited eye diseases. Objective: To try to identify the genes linked to the development of inherited eye diseases. Eligibility: People ages 4 and older who have or have a family member with an inherited eye disease Design: Participants will be screened with medical history and medical records. Participants will have one visit that will take 3-4 hours. This will include: Medical and family history Eye exam: This includes the pupil being dilated. Electroretinography: A small electrode is taped to the forehead. Participants sit in the dark with their eyes patched for 30 minutes. Then numbing drops and contact lenses are put in the eyes. They will watch flashing lights. Blood tests Saliva sample: They will spit into a container or have the inside of their cheek swabbed. Genetic testing will be done on participants blood or saliva. Participants may meet with the researchers to discuss their genetic tests.
Primary Outcome
Provide improved diagnosis and categorization of inherited visual disorders and should eventually suggest rationales for prevention or delay of both Mendelian and complex eye diseases
Conditions Studied
Study Locations (10)
Other
- Eye Research Institute, Zhongshan Ophthalmic Center, Sun Yat Sen University - Guangzhou
- Aravind Medical Research Foundation - Madurai
- Seconda Universita di Napoli - Naples
- National Centre of Excellence in Molecular Biology, University of the Punjab - Lahore
- University of the Philippines - Manila
- The Filatov Institute of Eye Disease and Tissue Therapy of the National Academy - Odesa
- University of Exeter - Exeter
California
- University of California, San Diego - La Jolla
Maryland
- National Institutes of Health Clinical Center - Bethesda
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2016-10-04 |
| Est. Completion | 2032-01-01 |
What NCT02771236 shows while recruiting
NCT02771236 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Inherited Eye Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02771236 lists 10 locations in 4 states (Other, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT02771236 about?
NCT02771236 is a clinical study titled "Clinical and Molecular Studies in Families With Inherited Eye Disease". Background: Genes are the basic units of heredity. When genes are changed, certain cells don t work like they should. Researchers want to try to better understand the genetic conditions that are linked with inherited eye diseases. Objective: To try to identify the genes linked to the development ...
What is the current status of trial NCT02771236?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2016-10-04. Estimated completion is 2032-01-01.
What conditions does trial NCT02771236 study?
This clinical trial studies the following conditions: Inherited Eye Disease.
Who is sponsoring clinical trial NCT02771236?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02771236 being conducted?
This trial has 10 study locations across California, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI